Xiaodong Zhang

ORCID: 0000-0003-3260-870X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Ferroptosis and cancer prognosis
  • RNA modifications and cancer
  • Epigenetics and DNA Methylation
  • Hepatitis B Virus Studies
  • Hepatitis C virus research
  • RNA Interference and Gene Delivery
  • Cancer-related molecular mechanisms research
  • Liver Disease Diagnosis and Treatment
  • Ubiquitin and proteasome pathways
  • Cancer-related gene regulation
  • CRISPR and Genetic Engineering
  • Cancer, Lipids, and Metabolism
  • MicroRNA in disease regulation
  • Transplantation: Methods and Outcomes
  • Rabies epidemiology and control
  • Virology and Viral Diseases
  • Cancer, Hypoxia, and Metabolism
  • RNA and protein synthesis mechanisms
  • Virus-based gene therapy research
  • Peptidase Inhibition and Analysis
  • Histone Deacetylase Inhibitors Research
  • Protein Degradation and Inhibitors
  • PI3K/AKT/mTOR signaling in cancer

Tianjin Medical University Cancer Institute and Hospital
2021-2024

Longyan University
2021

Shaoxing University
2013

Abstract Hepatitis B virus (HBV) infection is a major driver of hepatocarcinogenesis. Ferroptosis type iron-mediated cell death that can suppress liver transformation. Previous studies have linked HBV to ferroptosis in fibrosis and acute failure. However, whether involved HBV-mediated cancer poorly understood. Here, we identified heat shock protein family A member 8 (HSPA8) as crucial host factor modulates replication cancer. X (HBx) upregulated HSPA8 by coactivating the transcription 1...

10.1158/0008-5472.can-22-3169 article EN Cancer Research 2023-02-06

Background & AimsThe programmed death-ligand 1 (PD-L1) is a major co-inhibitory checkpoint factor that controls T cell activities in tumors. PD-L1 expressed on immune cells and tumor cells. Whether cell-expressed affects an cell-independent fashion remains largely elusive. Here, we investigated the significance of with focus downstream signals changes lipid metabolism.MethodsImmune-independent functions growth were vitro immuno-deficient mice vivo. The global influence targeted/untargeted...

10.1016/j.jhepr.2024.101009 article EN cc-by-nc-nd JHEP Reports 2024-01-21

Nucleus(t)ide analogs (NAs), containing Lamivudine (LMV), adefovir dipivoxil (ADV), endeavor (ETV), telbivudine (LdT), and tenofovir (TDF) are widely used for the treatment of chronic hepatitis B (CHB), but long term anti-Hepatitis virus (HBV) therapy with NAs may give rise to emergence drug-resistant viral mutants.This study aimed find identify some new resistance mutations HBV from patients accepted anti-HBV therapy.The reverse transcriptase (RT) coding region was PCR-amplified using DNA...

10.5812/hepatmon.12160 article EN cc-by-nc Hepatitis Monthly 2013-09-25

Protein arginine methyltransferase 5 (PRMT5) acts as an oncogene in liver cancer, yet its roles and in-depth molecular mechanisms within the cancer immune microenvironment remain mostly undefined. Here, we demonstrated that disruption of tumor-intrinsic PRMT5 enhances CD8+ T-cell-mediated antitumor immunity both vivo vitro. Further experiments verified this effect is achieved through downregulation inhibitory checkpoint molecule, fibrinogen-like protein 1 (FGL1). Mechanistically, catalyzed...

10.1016/j.apsb.2024.10.016 article EN cc-by-nc-nd Acta Pharmaceutica Sinica B 2024-11-05

<div>Abstract<p>Hepatitis B virus (HBV) infection is a major driver of hepatocarcinogenesis. Ferroptosis type iron-mediated cell death that can suppress liver transformation. Previous studies have linked HBV to ferroptosis in fibrosis and acute failure. However, whether involved HBV-mediated cancer poorly understood. Here, we identified heat shock protein family A member 8 (HSPA8) as crucial host factor modulates replication cancer. Hepatitis X (HBx) upregulated HSPA8 by...

10.1158/0008-5472.c.6514397.v1 preprint EN 2023-03-31

<div>Abstract<p>Hepatitis B virus (HBV) infection is a major driver of hepatocarcinogenesis. Ferroptosis type iron-mediated cell death that can suppress liver transformation. Previous studies have linked HBV to ferroptosis in fibrosis and acute failure. However, whether involved HBV-mediated cancer poorly understood. Here, we identified heat shock protein family A member 8 (HSPA8) as crucial host factor modulates replication cancer. Hepatitis X (HBx) upregulated HSPA8 by...

10.1158/0008-5472.c.6514397 preprint EN 2023-03-31

<div>Abstract<p>Hepatitis B virus (HBV) infection is a major driver of hepatocarcinogenesis. Ferroptosis type iron-mediated cell death that can suppress liver transformation. Previous studies have linked HBV to ferroptosis in fibrosis and acute failure. However, whether involved HBV-mediated cancer poorly understood. Here, we identified heat shock protein family A member 8 (HSPA8) as crucial host factor modulates replication cancer. Hepatitis X (HBx) upregulated HSPA8 by...

10.1158/0008-5472.c.6514397.v2 preprint EN 2023-04-04

Hepatitis B is a chronic infectious disease caused by hepatitis virus (HBV) infection, with liver inflammatory lesions as the main clinical manifestation, and continuous replication of HBV can lead to abnormal function, cirrhosis, even cancer. At present, variety anti-HBV drugs have been applied in practice, but no satisfactory therapeutic effect has achieved. Therefore, it urgent develop new constantly update concept treatment. This article reviews research advances that block interaction...

10.3969/j.issn.1001-5256.2021.05.001 article EN 临床肝胆病杂志 2021-05-15
Coming Soon ...